Circulating Tumor Cells (CTCs) are a type of biomarker used to detect and monitor cancer. CTCs are cells that have been shed from a tumor and are present in the bloodstream. They can be used to diagnose cancer, monitor its progression, and assess the effectiveness of treatments. CTCs are also used to identify new therapeutic targets and to develop personalized treatments. CTCs are a rapidly growing market, with a range of products and services available to researchers and clinicians. Companies in the CTC market offer technologies for isolating, analyzing, and characterizing CTCs, as well as services for CTC-based diagnostics and drug development. Examples of companies in the CTC market include ApoCell, Menarini Silicon Biosystems, and RareCyte. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
